Journal of Hepatology Citation Rate 2026
0168-8278
eISSN 1600-0641
Elsevier BV
DK
Q2 Quartile
About Journal of Hepatology
Journal of Hepatology (JH) is a peer-reviewed academic journal, published by Elsevier BV in DK, catalogued under ISSN 0168-8278 (e-ISSN 1600-0641). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.99 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Journal of Hepatology Citation Rate 2026 — In Context
Journal of Hepatology has a 2025 2-Year Citation Rate (OpenAlex) of 1.99, placing it in the Q2 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Journal of Hepatology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Journal of Hepatology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Journal of Hepatology against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 0168-8278 |
|---|---|
| ISSN (Online) | 1600-0641 |
| Publisher | Elsevier BV |
| Country | Denmark |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Journal of Hepatology is published by Elsevier BV and based in Denmark.
Its most recent citation rate stands at 1.994.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Journal of Hepatology
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.994 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches
Jenyfer M Fuentes-Mendoza, Marcio J Concepción-Zavaleta, Jeny J Mendoza-Godoy • 2026
-
From steatosis to inflammation: Innate lymphocytes as hidden orchestrators in metabolic dysfunction-associated steatotic liver disease
César Alejandro San Juan-García, Rita I Escamilla, Lucia Cruz-Romero • 2026
-
Acute liver failure linked to OxyShred pre-workout supplement: A case report and review of literature
Sarah Householder, Noah Brazer, Ysabel C Ilagan-Ying • 2026
-
Survival gap in gallbladder cancer: Bridging tumor biology and healthcare system logistics
Bruno Mirandola Bulisani • 2026
-
Anti-obesity medications, the new frontiers in metabolic dysfunction-associated fatty liver disease: Efficacy, limitations, and future directions
Yasser Fouad, Wafaa A Abdelghany, Reem El Sheemy • 2026
Explore More Journals
Metadata
Last updated: Jul 12, 2026
Updated by: system
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.